Obsidian Therapeutics (OBX)
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investig...
- Open
- 19.260
- High
- 20.200
- Low
- 16.310
- Prev. Close
- 17.535
- Volume
- 112.27K
- Turnover
- 2.15M
- Avg Price
- 19.158
- Bid/Ask Ratio
- -53.85%
- Amplitude
- 22.18%
- 52wk High
- 49.970
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Obsidian Therapeutics Analyst Rating
View moreForecast & Rating
Aug 6, 2026Price forecast
$42.00110.53%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Price Alert · 4 hours ago
U.S. stock market midday update: Obsidian Therapeutics up 13.66%, capital activity intensifies
- benzinga_article · Aug 14 at 04:06 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga_article · Aug 13 at 12:05 PM
12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga_article · Aug 5 at 09:20 AM
This Civeo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
- StockTitan · Aug 4 at 10:05 PM
Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma | OBX Stock News
